Grifols (GIFLF) Revenue (2010 - 2025)
Grifols' (GIFLF) quarterly Revenue came in at $8.8 billion in Q4 2025, up 13.64% on a YoY basis from $7.7 billion in Q4 2024, and up 13.64% quarter-over-quarter from $7.7 billion in Q4 2024.
Analysis
Grifols (GIFLF) Revenue (2010 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Revenue for 14 consecutive years, with $8.8 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 13.64% year-over-year to $8.8 billion; the trailing twelve-month figure through Dec 2025 stood at $16.5 billion (up 79.55% YoY), and the FY2025 full-year result was $8.5 billion, up 4024.05% from the prior year.
- Revenue improved to $8.8 billion in Q4 2025 per GIFLF's latest filing, from $7.7 billion in the prior quarter.
- Across five years, Revenue topped out at $8.8 billion in Q4 2025 and bottomed at $44.3 million in Q4 2021.
- Historically, Revenue has averaged $5.5 billion across 3 years, with a median of $7.7 billion in 2024.
- The sharpest annual moves came in 2021 and 2025: Revenue advanced 20.73% in 2021, then grew 13.64% in 2025.
- Over 3 years, Revenue stood at $44.3 million in 2021, then soared by 17296.98% to $7.7 billion in 2024, then rose by 13.64% to $8.8 billion in 2025.
- According to Business Quant data, Revenue over the past three periods registered $8.8 billion, $7.7 billion, and $44.3 million for Q4 2025, Q4 2024, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 8.76 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.76 Bn |
| Dec 31, 2024 | 7.71 Bn |
| Dec 31, 2021 | 44.30 Mn |
| Dec 31, 2020 | 36.69 Mn |
| Mar 31, 2020 | 1.43 Bn |
| Dec 31, 2019 | 4.14 Bn |
| Mar 31, 2019 | 1.31 Bn |
| Dec 31, 2018 | 3.73 Bn |
| Sep 30, 2018 | 1.33 Bn |
| Jun 30, 2018 | 1.31 Bn |
| Mar 31, 2018 | 1.26 Bn |
| Dec 31, 2017 | 3.83 Bn |
| Jun 30, 2017 | 1.24 Bn |
| Mar 31, 2017 | 1.13 Bn |
| Dec 31, 2016 | 2.11 Bn |
| Sep 30, 2016 | 1.12 Bn |
| Jun 30, 2016 | 1.12 Bn |
| Mar 31, 2016 | 1.06 Bn |
| Dec 31, 2015 | 1.16 Bn |
| Sep 30, 2015 | 1.08 Bn |